4
Changes in Ownership
MBX Biosciences, Inc. Filed Acc 0000950170-25-014494
President & CEO bought 50,000 shares at $10.69 ($534,500)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hawryluk P. Kent President & CEO | 2025-02-04 | Purchase | +50,000 | $10.69 | $534,500 | 448,277 | I |
| Derivatives | |||||||
| Hawryluk P. Kent President & CEO | 2025-02-03 | Grant or award · Stock Option (Right to Buy) | +243,000 | 243,000 | D | ||
| Open-market purchases · 50,000 sh · avg $10.69 · $534,500 | |||||||
Loading xslF345X05/ownership.xml…